https://www.selleckchem.com/products/az-3146.html
137) and CA1 (left P.001, η =0.137; right P=.006, η =0.07. Subiculum and CA1 atrophy from clinical MRI may be a promising in vivo biomarker for HS. Subiculum and CA1 atrophy from clinical MRI may be a promising in vivo biomarker for HS.Sarcoidosis-lymphoma syndrome describes a pathological state wherein both sarcoidosis and lymphoma are present. Sarcoidosis and lymphoma may occur concurrently, or sarcoidosis may precede lymphoma. There are few reports which have previously described the temporal progression from lymphoma to sarcoi
Like
Comment
Share
